Professor Fatih Selcukbiricik
5
reviews
He is a fine oncologist and mentor. He arranged chemotherapy, radiotherapy, and the necessary operations in sequence and was always there for us as our doctor.
He is one of those rare people you can meet in life. One of those rare doctors who have not lost their soul. A legendary person. Just like his surname — one of a kind, full of love, and our wonderful doctor.
27/09/2018
Thanks to his approach to patients and his outstanding professional achievements, he was always by our side in this merciless fight against the disease. Tremendous gratitude to our dear teacher Fatih Bey and his team.
Entrusting the treatment of our patient Serkan Dursun on July 19, 2019 to your hands was the most correct decision in our lives. Thank God, our long and exhausting treatment journey with you has come to a successful end.
I cannot find words to express this joy and gratitude. Knowing that there are doctors like you is itself a source of happiness.
02/11/2019
We were truly very pleased with him — the treatment, follow-up, and human attitude were all excellent.
30/04/2014
Throughout the treatment, our admiration grew with every visit — we believe he is one of the best in his field.
Over the course of this illness we came to realize how few specialists like Fatih Bey there are in our country. Thank you for all his efforts. We wanted to express our gratitude here as well.
10/04/2014
He treats his patients both politely and attentively. He gives patients plenty of his time.
I unequivocally recommend him.
31/10/2013
Professor Fatih Selcukbiricik is a medical oncologist from Istanbul, focused on the modern systemic therapy of solid tumors: chemotherapy, targeted therapy, and immunotherapy.
He was born in 1974 in Akşehir and graduated from the Cerrahpaşa Faculty of Medicine of Istanbul University in 1999. He completed his residency in internal medicine at Istanbul Faculty of Medicine in 2005, and from 2009–2012 he completed a subspecialty fellowship in medical oncology.
Since September 2014 he has been working at Koç University Hospital and is also a faculty member at Koç University School of Medicine.
Professor Selcukbiricik is actively involved in national multicenter clinical trials dedicated to checkpoint-inhibitor immunotherapy in various tumors, including lung cancer with EGFR and BRAF mutations, breast cancer (TNBC and HR+/HER2– with the antibody-drug conjugate sacituzumab govitecan), and urological tumors.
He has more than 150 peer-reviewed scientific publications to his credit.
Achievements and awards
About Doctor Fatih Selcukbiricik
Medical oncology and systemic treatment of oncological diseases.
Main areas of specialization:
- treatment of colorectal cancer;
- treatment of stomach cancer and other gastrointestinal tumors;
- treatment of pancreatic cancer;
- treatment of lung cancer;
- treatment of breast cancer;
- treatment of gynecological oncological diseases;
- treatment of head and neck tumors;
- treatment of urological oncological diseases;
- chemotherapy;
- targeted therapy;
- immunotherapy;
- personalized systemic cancer treatment;
- management of patients with metastatic forms of cancer;
- multidisciplinary planning of treatment for oncology patients.
Special professional interests:
- gastrointestinal tumors;
- targeted therapy and immunotherapy;
- modern treatment regimens for advanced and metastatic forms of cancer.
- 1999 — Cerrahpaşa Faculty of Medicine, Istanbul University — Doctor of Medicine degree.
- 2005 — specialization in internal medicine, Faculty of Medicine, Istanbul University.
- 2009–2012 — fellowship in medical oncology, Cerrahpaşa Faculty of Medicine, Istanbul University.
- 2005–2009 — internal medicine physician, specialist in internal diseases.
- 2009–2012 — training in medical oncology.
- Since 2014 — Department of Medical Oncology, Koç University Hospital (Istanbul); faculty member of Koç University School of Medicine.
Author and co-author of more than 150 scientific publications in international medical journals.
Participates in international research on the treatment of lung cancer and pancreatic tumors, including modern methods of molecular diagnostics, targeted therapy, and immunotherapy.
- European Society for Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
- Turkish Society of Medical Oncology
Koç University Hospital — an academic private hospital of the Vehbi Koç Foundation, opened in 2014 in the Topkapı / Zeytinburnu district of Istanbul. A multidisciplinary center based at Koç University School of Medicine, closely affiliated with American Hospital (the same foundation) and exchanging specialists and protocols with the MD Anderson Radiation Treatment Center.
For oncology patients, the following are important: a Cancer Center with a multidisciplinary approach — medical oncology, radiation oncology (Varian Trilogy® linear accelerator and others), surgery, and interventional radiology (including experienced teams for ablation of liver metastases); active participation in international clinical trials, giving patients potential access to drugs not yet registered for routine use; modern diagnostic equipment (CT, MRI, PET/CT, NGS sequencing); and an international patient department with interpreters.
